VKTX ▲ +28.7% - Viking Therapeutics, Inc. $VKTX - UP TO 97% WEIGHT LOSS MAINTAINED WITH EVERY-OTHER-WEEK DOSING FOR THREE MONTHS Viking Therapeutics shares surged 28.7% after the company reported that patients maintained up to 97% of their weight loss with every-other-week dosing over a three-month period. The finding suggests the company's therapeutic candidate could offer a more convenient dosing schedule, a potential competitive advantage in the obesity treatment market where patient adherence is a key consideration. 22-SEP-2026 07:05 AM ET